Switzerland was the first country in the world to approve the Pfizer-BioNTech vaccine in “standard procedures”.
Swissmedic, the institution that regulates the regulations in the field of treatment and health in Switzerland. Approved the new type of coronavirus (Coid-19) vaccine developed by Pfizer and BioNTech.
Switzerland became the first country in the world to approve the vaccine for “emergency use” of Pfizer and BioNTech in the UK, Canada and the USA.
In a written statement made by Swissmedic, it stated that the data obtained from all age groups. Showed that the vaccine meets “high efficiency and safety requirements”. In the statement, it emphasized that the vaccine approved under “standard procedures”, not for emergency use, and this was a first in the world.
Swissmedic Director Raimund Bruhin stated that they acted meticulously during the approval process. He stated that the vaccine developed by Pfizer and BioNTech meets the “safety, efficacy and quality” criteria.
“Patient safety is an important prerequisite, especially when it comes to licensing vaccines,” says Bruhin. used the expression.
Switzerland has ordered a total of 15.8 million doses of Covid-19 vaccines developed by Moderna and AstraZeneca, as well as Pfizer and BioNTech vaccine.
The vaccine will be free
Swiss Health Minister Alain Berset stated in a statement on Twitter that vaccination will begin within days. Barset stressed that the vaccine is free and they “strongly” recommend it.
According to the plans, widespread vaccination in the country is expected to begin with the first batch of 100,000 doses as of January 4. Vaccination campaign that will last until summer. 6 million people are plan to vaccinated. Switzerland, which consists of 26 cantons and has a population of 8.5 million. All the measures taken by the Federal Government and cantons were insufficient to stop the pace of the Covid-19 outbreak.